149 related articles for article (PubMed ID: 6871482)
1. Heterogeneity of estrogen binding sites in mammary tumors.
Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
[TBL] [Abstract][Full Text] [Related]
2. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of estrogen binding sites in mouse mammary cancer.
Watson CS; Clark JH
J Recept Res; 1980; 1(1):91-111. PubMed ID: 7299733
[No Abstract] [Full Text] [Related]
4. Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors.
Vignon F; Rochefort H
Cancer Res; 1978 Jun; 38(6):1808-14. PubMed ID: 647690
[TBL] [Abstract][Full Text] [Related]
5. Effects of plasma estrogen sulfates in mammary cancer cells.
Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
[No Abstract] [Full Text] [Related]
6. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
[TBL] [Abstract][Full Text] [Related]
7. Fluctuations in levels of cytosol and nuclear estrogen receptors in rat mammary tumors during the estrous cycle.
Shih A; Lee C
Endocrinology; 1978 Feb; 102(2):420-5. PubMed ID: 570481
[No Abstract] [Full Text] [Related]
8. Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.
Watson CS; Medina D; Clark JH
Endocrinology; 1980 Nov; 107(5):1432-7. PubMed ID: 7428677
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors.
Rochefort H; André J; Baskevitch PP; Kallos J; Vignon F; Westley B
J Steroid Biochem; 1980 Jan; 12():135-42. PubMed ID: 7421202
[No Abstract] [Full Text] [Related]
10. Methyl p-hydroxyphenyllactate and nuclear type II binding sites in malignant cells: metabolic fate and mammary tumor growth.
Markaverich BM; Gregory RR; Alejandro M; Kittrell FS; Medina D; Clark JH; Varma M; Varma RS
Cancer Res; 1990 Mar; 50(5):1470-8. PubMed ID: 2302712
[TBL] [Abstract][Full Text] [Related]
11. Nuclear type II sites and malignant cell proliferation: inhibition by 2,6-bis-benzylidenecyclohexanones.
Markaverich BM; Schauweker TH; Gregory RR; Varma M; Kittrell FS; Medina D; Varma RS
Cancer Res; 1992 May; 52(9):2482-8. PubMed ID: 1568218
[TBL] [Abstract][Full Text] [Related]
12. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
[No Abstract] [Full Text] [Related]
13. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
Schoenberg DR; Clark JH
Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
[TBL] [Abstract][Full Text] [Related]
14. Inter-site variation of oestrogen receptors in human breast cancers.
Tilley WD; Keightley DD; Cant EL
Br J Cancer; 1978 Oct; 38(4):544-6. PubMed ID: 728342
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of malignant breast tumors containing estrogen receptors].
El'tsina NV
Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
[No Abstract] [Full Text] [Related]
16. Nuclear uptake of oestradiol-17 beta in human mammary tumour tissue.
Thorsen T; Stoa KF
J Steroid Biochem; 1979 Jun; 10(6):595-9. PubMed ID: 470382
[TBL] [Abstract][Full Text] [Related]
17. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
18. An improved assay for nuclear estrogen receptor in experimental and human breast cancer.
Garola RE; McGuire WL
Cancer Res; 1977 Sep; 37(9):3333-7. PubMed ID: 884677
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors.
Migliaccio A; Pagano M; De Goeij CC; Di Domenico M; Castoria G; Sluyser M; Auricchio F
Int J Cancer; 1992 Jul; 51(5):733-9. PubMed ID: 1612782
[TBL] [Abstract][Full Text] [Related]
20. Hormone dependence in breast cancer.
McGuire WL; Chamness GC; Costlow ME; Shepherd RE
Metabolism; 1974 Jan; 23(1):75-100. PubMed ID: 4357247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
